Application

Trademark

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97810745
Filing Date: 02/24/2023

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97810745
MARK INFORMATION
*MARK TRIVENI
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TRIVENI
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Amagma, Inc.
*MAILING ADDRESS 100 Beaver Street, Suite 307
*CITY Waltham
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02453
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS  
*IDENTIFICATION Pharmaceutical, therapeutic and biopharmaceutical agents; pharmaceutical, therapeutic and biopharmaceutical preparations and substances; biological preparations, namely, antibodies; research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; DNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Christina M. Licursi
ATTORNEY DOCKET NUMBER M16022000000
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Wolf, Greenfield & Sacks, P.C.
STREET 600 Atlantic Avenue
CITY Boston
STATE Massachusetts
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 02210
PHONE 617-646-8000
FAX 617-646-8646
EMAIL ADDRESS cxltrademarks@wolfgreenfield.com
OTHER APPOINTED ATTORNEY Saad Alam, Michael A. Albert, Nicole Davis Amar, Michael J. Attisha, C. Hunter Baker, Jason W. Balich, Melissa Beede, Brandon S. Blackwell, Joseph M. Bowler, Kady S. Bruce, David F. Cauble, Tani Chen, Gitanjali Chimalakonda, Thomas S. Chlebeck, Aya Cieslak-Tochigi, Bryan S. Conley, Gregory F. Corbett, William L. Czaplyski, Cara B. Dawson, Trevor R. Day, Elizabeth A. DiMarco, Heather J. DiPietrantonio, Matthew O. Duffey, Stuart V. Duncan Smith, Roque El-Hayek, Neil P. Ferraro, Emma L. Frank, Thomas A. Franklin, Susmita A. Gadre, Edward R. Gates, Jean Ge, David S. Gesner, Richard F. Giunta, Gregory J. Gonsalves, Matthew H. Grady, Patricia L. Granahan, Blaine M. Hackman, Philip J. Hamzik, James M. Hanifin, Jr., Steven F. Hannigan, John S. Harmon, Jason M. Honeyman, Gerald B. Hrycyszyn, Jeffrey D. Hsi, Elisabeth H. Hunt, Robert E. Hunt, Daniel M. Huttle, Robert A. Jensen, Marc S. Johannes, Oona M. Johnstone, Quincy L. Kayton, Hunter D. Keeton, Alexandra K. Kim, Jessamine M. Lee, Kevin Y. Li, Lin Li, Christina M. Licursi, Helen C. Lockhart, Chelsea Loughran, Flora Luo, Yue Matthew Ma, Kevin MacDonald, Robert T. Maldonado, John L. Marquardt, Kira-Khanh McCarthy, William R. McClellan, Marie A. McKiernan, Michele Moresco, James H. Morris, Elizabeth S. Mulski, Gregory S. Nieberg, Michelle K. Nyein, Timothy J. Oyer, Usha K. M. Parker, Zachary P. Piccolomini, Michael J. Pomianek, Curtis R. Powell, Randy J. Pritzker, Haiou Qin, Stephen S. Rabinowitz, Michael N. Rader, Sushmitha Rajeevan, Suresh Rav, Laura B. Rogers, Jonathan B. Roses, Daniel G. Rudoy, Edward J. Russavage, Eric J. Rutt, Robert N. Sahr, Anant K. Saraswat, Turhan F. Sarwar, Tonia A. Sayour, Amanda Slade, Nathan R. Speed, Charles T. Steenburg, Charlotte R. Stewart-Sloan, John L. Strand, Maria A. Trevisan, Michael J. Twomey, John R. Van Amsterdam, Ryan M. Van Olst, Andrew R. Varrenti, Amanda L. Varrichione, Janice A. Vatland, Jessica A. vonReyn, Robert H. Walat, Patrick R.H. Waller, Edmund J. Walsh, Jennifer J. Wang, Anne E. Weeks, John L. Welch, Adam R. Wichman, Andrew W. Williams, Chelsea E. Witte-Garcia, Douglas R. Wolf, Jie Xiang, Daniel W. Young, Lock See Yu-Jahnes, Adam Z. Zeiger, William Wei Zhang, Norman H. Zivin
CORRESPONDENCE INFORMATION
NAME Christina M. Licursi
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE cxltrademarks@wolfgreenfield.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
       ORIGINAL PDF FILE hw_1736820178-154109630_. _M1602.20000US00_TRIVENI_ -_signed.pdf
       CONVERTED PDF FILE(S)
       (4 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\978\107\97810745\xml1\ APP0006.JPG
SIGNATORY'S NAME Nicholas Scarchilli
SIGNATORY'S POSITION CBO, Amagma
SIGNATURE METHOD Handwritten



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97810745
Filing Date: 02/24/2023

To the Commissioner for Trademarks:

MARK: TRIVENI (Standard Characters, see below )

The literal element of the mark consists of TRIVENI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Amagma, Inc., a corporation of Delaware, having an address of
      100 Beaver Street, Suite 307
      Waltham, Massachusetts 02453
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class _______: Pharmaceutical, therapeutic and biopharmaceutical agents; pharmaceutical, therapeutic and biopharmaceutical preparations and substances; biological preparations, namely, antibodies; research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; DNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Christina M. Licursi. Other appointed attorneys are Saad Alam, Michael A. Albert, Nicole Davis Amar, Michael J. Attisha, C. Hunter Baker, Jason W. Balich, Melissa Beede, Brandon S. Blackwell, Joseph M. Bowler, Kady S. Bruce, David F. Cauble, Tani Chen, Gitanjali Chimalakonda, Thomas S. Chlebeck, Aya Cieslak-Tochigi, Bryan S. Conley, Gregory F. Corbett, William L. Czaplyski, Cara B. Dawson, Trevor R. Day, Elizabeth A. DiMarco, Heather J. DiPietrantonio, Matthew O. Duffey, Stuart V. Duncan Smith, Roque El-Hayek, Neil P. Ferraro, Emma L. Frank, Thomas A. Franklin, Susmita A. Gadre, Edward R. Gates, Jean Ge, David S. Gesner, Richard F. Giunta, Gregory J. Gonsalves, Matthew H. Grady, Patricia L. Granahan, Blaine M. Hackman, Philip J. Hamzik, James M. Hanifin, Jr., Steven F. Hannigan, John S. Harmon, Jason M. Honeyman, Gerald B. Hrycyszyn, Jeffrey D. Hsi, Elisabeth H. Hunt, Robert E. Hunt, Daniel M. Huttle, Robert A. Jensen, Marc S. Johannes, Oona M. Johnstone, Quincy L. Kayton, Hunter D. Keeton, Alexandra K. Kim, Jessamine M. Lee, Kevin Y. Li, Lin Li, Christina M. Licursi, Helen C. Lockhart, Chelsea Loughran, Flora Luo, Yue Matthew Ma, Kevin MacDonald, Robert T. Maldonado, John L. Marquardt, Kira-Khanh McCarthy, William R. McClellan, Marie A. McKiernan, Michele Moresco, James H. Morris, Elizabeth S. Mulski, Gregory S. Nieberg, Michelle K. Nyein, Timothy J. Oyer, Usha K. M. Parker, Zachary P. Piccolomini, Michael J. Pomianek, Curtis R. Powell, Randy J. Pritzker, Haiou Qin, Stephen S. Rabinowitz, Michael N. Rader, Sushmitha Rajeevan, Suresh Rav, Laura B. Rogers, Jonathan B. Roses, Daniel G. Rudoy, Edward J. Russavage, Eric J. Rutt, Robert N. Sahr, Anant K. Saraswat, Turhan F. Sarwar, Tonia A. Sayour, Amanda Slade, Nathan R. Speed, Charles T. Steenburg, Charlotte R. Stewart-Sloan, John L. Strand, Maria A. Trevisan, Michael J. Twomey, John R. Van Amsterdam, Ryan M. Van Olst, Andrew R. Varrenti, Amanda L. Varrichione, Janice A. Vatland, Jessica A. vonReyn, Robert H. Walat, Patrick R.H. Waller, Edmund J. Walsh, Jennifer J. Wang, Anne E. Weeks, John L. Welch, Adam R. Wichman, Andrew W. Williams, Chelsea E. Witte-Garcia, Douglas R. Wolf, Jie Xiang, Daniel W. Young, Lock See Yu-Jahnes, Adam Z. Zeiger, William Wei Zhang, Norman H. Zivin. Christina M. Licursi of Wolf, Greenfield & Sacks, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      600 Atlantic Avenue
      Boston, Massachusetts 02210
      United States
      617-646-8000(phone)
      617-646-8646(fax)
      cxltrademarks@wolfgreenfield.com
The docket/reference number is M16022000000.
Christina M. Licursi submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Christina M. Licursi
       PRIMARY EMAIL FOR CORRESPONDENCE: cxltrademarks@wolfgreenfield.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature
The attached signature image file:
\\TICRS\EXPORT18\IMAGEOUT18\978\107\97810745\xml1\APP0003.JPG



Signatory's Name: Nicholas Scarchilli
Signatory's Position: CBO, Amagma
Signatory's Phone Number: Not Provided
Signature method: Handwritten
Payment Sale Number: 97810745
Payment Accounting Date: 02/24/2023

Serial Number: 97810745
Internet Transmission Date: Fri Feb 24 16:01:22 ET 2023
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XXX-2023022416012339
7293-97810745-86049bf1322763be1cbc4439bf
e6a794c4330ed715a8fad77b7532f755ace6b20a
-CC-01227843-20230224154109630155

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed